Matthew Ho MD PhD

PubMed

• Extramedullary Multiple Myeloma: Challenges and Opportunities.
  Matthew Ho, Luca Paruzzo, Janna Minehart, Neel Nabar, Julia Han Noll
  Current Oncology. 2025-03-20
• Nontuberculous mycobacterial infections following teclistamab in multiple myeloma.
  Matthew Ho, Luca Paruzzo, Janna Minehart, Teja Voruganti, Pooja Devi
  Haematologica. 2025-02-06
• 9 citations
  Chimeric antigen receptor T-cell therapy in hematologic malignancies: Successes, challenges, and opportunities.
  Matthew Ho, Saurabh Zanwar, Jonas Paludo
  European Journal of Haematology. 2024-02-01

Journal Articles

• Targeting Protein Synthesis and Degradation in Multiple Myeloma  
  Ho M, Bianchi G, American Journal of Hematology and Oncology
• Exploiting Autophagy in Multiple Myeloma  
  Ho M, Patel A, Hanley C, Murphy A, McSweeney T, Zhang L, McCann A, O’Gorman P, Bianchi G, Journal of Cancer Metastasis and Treatment
• ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment  
  Bianchi G, Czarnecki PG, Ho M, Roccaro AM, Sacco A, Kawano Y, Gulla A, Samur AA, Chen T, Wen K, Tai YT, Moscvin M, Wu X, Camci-Unal G, Claudio, M, Bolli N, Sewastianik..., Blood Cancer Discovery
• Proteomics inspired precision medicine for treating and understanding multiple myeloma  
  Ho M, Bianchi G, & Anderson KC, Expert Review of Precision Medicine and Drug Development 2020, 2/20/2020
• Join now to see all